| Erin Maetzold, MD | |
|
3000 32nd Ave S, Fargo, ND 58103-6132 | |
| (017) 364-8000 | |
| Not Available |
| Full Name | Erin Maetzold |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology - Female Pelvic Medicine And Reconstructive Surgery |
| Location | 3000 32nd Ave S, Fargo, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518378488 | NPI | - | NPPES |
| Entity Name | State University Of Iowa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477554814 PECOS PAC ID: 7618884230 Enrollment ID: O20031107000060 |
News Archive
New guidance has been published on managing diabetes in the elderly, including for the first time how to manage treatment for the particularly frail.
Eli Lilly and Company today announced encouraging results from a one-year pilot study examining the effect of ruboxistaurin mesylate in persons with type 2 diabetes and kidney disease (also known as "diabetic nephropathy").
"Glucocorticoids are a key component of combination therapy regimens in multiple myeloma and other hematological cancers. However, glucocorticoid use comes with substantial dose limiting toxicities. The ability to enhance glucocorticoid dependent effects while sparing associated toxicities may have important implications for the treatment of multiple myeloma and other B-cell malignancies"
Most Canadians living with CKD have likely never spoken with their physicians about calcium and the serious health risks associated with its overuse. This is why Improving Patient Advocacy in Chronic Kidney Disease (ImPACKD), a group of CKD patients and caregivers committed to raising awareness about the risks of calcium overuse, is starting the conversation about the importance of knowing the limits and keeping them in check.
Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal Arthritis and Rheumatism.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erin Maetzold, MD 1702 University Dr S, Fargo, ND 58103-4940 Ph: () - | Erin Maetzold, MD 3000 32nd Ave S, Fargo, ND 58103-6132 Ph: (017) 364-8000 |
News Archive
New guidance has been published on managing diabetes in the elderly, including for the first time how to manage treatment for the particularly frail.
Eli Lilly and Company today announced encouraging results from a one-year pilot study examining the effect of ruboxistaurin mesylate in persons with type 2 diabetes and kidney disease (also known as "diabetic nephropathy").
"Glucocorticoids are a key component of combination therapy regimens in multiple myeloma and other hematological cancers. However, glucocorticoid use comes with substantial dose limiting toxicities. The ability to enhance glucocorticoid dependent effects while sparing associated toxicities may have important implications for the treatment of multiple myeloma and other B-cell malignancies"
Most Canadians living with CKD have likely never spoken with their physicians about calcium and the serious health risks associated with its overuse. This is why Improving Patient Advocacy in Chronic Kidney Disease (ImPACKD), a group of CKD patients and caregivers committed to raising awareness about the risks of calcium overuse, is starting the conversation about the importance of knowing the limits and keeping them in check.
Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal Arthritis and Rheumatism.
› Verified 5 days ago
Zena Kay Homan, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 Fax: 701-364-8078 | |
Jeffrey Allen Rondeau, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2400 32nd Ave S, Fargo, ND 58103 Phone: 701-234-8880 Fax: 701-234-8995 | |
Christine Keup, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2241 | |
Dr. John Michael Balintona, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 Fax: 701-364-8078 | |
Margaret Traynor Mickelson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2241 Fax: 701-234-4877 | |
Dr. Denise M Schumacher, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4450 31st Ave S Ste 102, Fargo, ND 58104 Phone: 012-802-0337 Fax: 701-232-5578 | |
Walter C Bro, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2000 Fax: 701-234-4877 |